Mechanisms for Organ Dysfunction in Covid-19

NCT04316884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2026-01-12

No results posted yet for this study

Summary

The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.

Conditions

  • COVID-19
  • Organ Dysfunction Syndrome Sepsis
  • Organ Dysfunction Syndrome, Multiple
  • Septic Shock
  • Acute Kidney Injury
  • Acute Respiratory Distress Syndrome

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Robert Frithiof, MD. PhD · Uppsala University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-12
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04316884 on ClinicalTrials.gov